<VariationArchive RecordType="classified" VariationID="3445" VariationName="NM_000135.2(FANCA):c.1007_3066del" VariationType="Deletion" Accession="VCV000003445" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2015-06-28" MostRecentSubmission="2015-06-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18484" VariationID="3445">
      <GeneList>
        <Gene Symbol="FANCA" FullName="FA complementation group A" GeneID="2175" HGNC_ID="HGNC:3582" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89737549" stop="89816647" display_start="89737549" display_stop="89816647" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89803958" stop="89883064" display_start="89803958" display_stop="89883064" Strand="-" />
          </Location>
          <OMIM>607139</OMIM>
        </Gene>
        <Gene Symbol="LOC130059837" FullName="ATAC-STARR-seq lymphoblastoid active region 11420" GeneID="130059837" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89764970" stop="89765079" display_start="89764970" display_stop="89765079" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130059838" FullName="ATAC-STARR-seq lymphoblastoid active region 11421" GeneID="130059838" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89765240" stop="89765309" display_start="89765240" display_stop="89765309" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000135.2(FANCA):c.1007_3066del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" outerStart="89751224" innerStart="89751251" innerStop="89795352" outerStop="89795381" display_start="89751224" display_stop="89795381" variantLength="44158" Strand="-" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" outerStart="89817632" innerStart="89817659" innerStop="89861760" outerStop="89861789" display_start="89817632" display_stop="89861789" variantLength="44102" />
      </Location>
      <OtherNameList>
        <Name>EX12-31DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.(89751224_89751251)_(89795352_89795381)del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.(89751224_89751251)_(89795352_89795381)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.(89817632_89817659)_(89861760_89861789)del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.(89817632_89817659)_(89861760_89861789)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="nssv7487160" DB="dbVar" />
        <XRef ID="nsv1197597" DB="dbVar" />
        <XRef Type="Allelic variant" ID="607139.0007" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="LocationOnGenomeAndProductNotAligned">Deletion of exons 12-31 from FANCA is caused by genomic deletion originating in the flanking intronic regions.</Comment>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 11344308 to determine the location of this allele on the current reference sequence.</Comment>
      <Comment DataSource="NCBI curation" Type="public">44-kb genomic deletion of exons 12-31 plus flanking intronic sequences from FANCA.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000135.2(FANCA):c.1007_3066del AND Fanconi anemia complementation group A" Accession="RCV000003614" Version="3">
        <ClassifiedConditionList TraitSetID="883">
          <ClassifiedCondition DB="MedGen" ID="C3469521">Fanconi anemia complementation group A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-05-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2001-05-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-06-28" MostRecentSubmission="2015-06-28">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11344308</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="883" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9887" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Fanconi anemia, group A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Fanconi anemia complementation group A</ElementValue>
                <XRef ID="MONDO:0009215" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FANCA</ElementValue>
                <XRef Type="MIM" ID="227650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">FANCA-Related Fanconi Anemia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15170" />
                <XRef ID="15170" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA.</Attribute>
                <XRef ID="NBK1401" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301575</ID>
                <ID Source="BookShelf">NBK1401</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2008">
                <URL>http://www.fanconi.org/images/uploads/other/Guidelines_for_Diagnosis_and_Management.pdf</URL>
                <CitationText>Fanconi Anemia Research Fund, Guidelines for Diagnosis and Management, 2008 (See 2020 Update)</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2020">
                <URL>https://www.fanconi.org/images/uploads/other/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.pdf</URL>
                <CitationText>Fanconi Anemia Clinical Care Guidelines, Fifth Edition.</CitationText>
              </Citation>
              <XRef ID="84" DB="Orphanet" />
              <XRef ID="C3469521" DB="MedGen" />
              <XRef ID="MONDO:0009215" DB="MONDO" />
              <XRef Type="MIM" ID="227650" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23772" SubmissionDate="2015-06-22" DateLastUpdated="2015-06-28" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607139.0007_FANCONI ANEMIA, COMPLEMENTATION GROUP A" title="FANCA, EX12-31DEL_FANCONI ANEMIA, COMPLEMENTATION GROUP A" />
        <ClinVarAccession Accession="SCV000023772" DateUpdated="2015-06-28" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-05-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Tipping et al. (2001) identified an intragenic deletion of exons 12-31 of the FANCA gene as accounting for 60% of Fanconi anemia chromosomes in 46 unrelated Afrikaner FA (see FANCA, 227650) patients. Two other mutations, also deletions, accounted for an additional 20%. By genealogic investigation of 12 Afrikaner families with FA, they traced the major deletion to a French Huguenot couple who arrived at the Cape in 1688. The same mutation and haplotype was found in an FANCA patient from the western Ruhr region of Germany. It was thus possible that the major founder mutation was introduced into South Africa from that region. Rhinelanders were a substantial component of the crew of the ships of the Dutch East India Company, and about one-third of the original European population of the Cape were of German origin.</Attribute>
              <Citation>
                <ID Source="PubMed">11344308</ID>
              </Citation>
              <XRef DB="OMIM" ID="227650" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FANCA" />
          </GeneList>
          <Name>FANCA, EX12-31DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX12-31DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607139.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FANCONI ANEMIA, COMPLEMENTATION GROUP A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="23772" TraitType="Disease" MappingType="Name" MappingValue="FANCONI ANEMIA, COMPLEMENTATION GROUP A" MappingRef="Preferred">
        <MedGen CUI="C3469521" Name="Fanconi anemia complementation group A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

